Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
NUZ Announcements
Neurizon Initiates Dosing in HEALEY ALS…
NUZ
NEURIZON THERAPEUTICS LIMITED
Market sensitive
Neurizon Initiates Dosing in HEALEY ALS Platform Trial
Date and time
26 February 2026 at 8:10 pm
Announcement type
Company Update
Show details
Hide details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
NUZ announcement history
Recent NUZ announcements
Elanco representative appointed as Neurizon Board Observer
Neurizon Completes Initial Drawdown under R&D Facility
Appendix 4C & Quarterly Update
Neurizon Enters Strategic R&D Financing Facility
Melbourne investor briefing presentation
HEALEY Enrolment Complete - Topline Accelerated to Q2 CY27